Screening for diabetes in Indigenous populations using glycated haemoglobin: sensitivity, specificity, post‐test likelihood and risk of disease
- 23 June 2005
- journal article
- Published by Wiley in Diabetic Medicine
- Vol. 22 (7) , 833-839
- https://doi.org/10.1111/j.1464-5491.2005.01447.x
Abstract
Aims Screening for diabetes using glycated haemoglobin (HbA1c) offers potential advantages over fasting glucose or oral glucose tolerance testing. Current recommendations advise against the use of HbA1c for screening but test properties may vary systematically across populations, according to the diabetes prevalence and risk. We aimed to: (i) characterize the properties of test cut‐offs of HbA1c for diagnosis of diabetes relative to a diagnosis based on a fasting plasma glucose concentration of 7.0 mmol/l for high‐risk Indigenous populations; and (ii) examine test properties across a range of diabetes prevalence from 5 to 30%.Methods Data were collected from Aboriginal and Torres Strait Islander communities in Australia and a Canadian First Nations community (diabetes prevalence 12–22%) in the course of diabetes diagnostic and risk factor screening programmes (n = 431). Screening test properties were analyzed for the range of HbA1c observed (3–12.9%).Results In separate and pooled analyses, a HbA1c cut point of 7.0% proved the optimal limit for classifying diabetes, with summary analysis results of sensitivity = 73 (56–86)%, specificity = 98 (96–99)%, overall agreement (Youden's index) = 0.71, and positive predictive value (for an overall prevalence of 18%) = 88%. For diabetes prevalence from 5 to 30% the post‐test likelihood of having diabetes given HbA1c = 7.0% (positive predictive value) ranged from 62.7 to 93.2%; for HbA1c < 7.0%, the post‐test likelihood of having diabetes ranged from 4.5 to 27.7%.Conclusions The results converge with research on the likelihood of diabetes complications in supporting a HbA1c cut‐off of 7.0% in screening for diabetes in epidemiological research. Glycated haemoglobin has potential utility in screening for diabetes in high‐risk populations.Keywords
This publication has 38 references indexed in Scilit:
- Measuring Prevalence: Obesity, diabetes and associated cardiovascular risk factors among Torres Strait Islander peopleAustralian and New Zealand Journal of Public Health, 2002
- Effectiveness of a community-directed ‘healthy lifestyle’ program in a remote Australian Aboriginal communityAustralian and New Zealand Journal of Public Health, 2000
- Glycated Hemoglobin as an Indicator of Social Environmental Stress among Indigenous versus Westernized PopulationsPreventive Medicine, 1999
- Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO Consultation criteria, and 1985 WHO criteriaDiabetes Research and Clinical Practice, 1999
- Assessing the utility of glycated hemoglobinDiabetes Care, 1998
- Dietary Composition, Body Weight, and NIDDM: Comparison of high-fiber, high-carbohydrate, and modified-fat dietsDiabetes Care, 1995
- Mid-P Confidence Intervals: A Brief ReviewJournal of the Royal Statistical Society: Series D (The Statistician), 1995
- Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetesBMJ, 1994
- Evaluation of Capillary Collection System for HbA1c SpecimensDiabetes Care, 1992
- Determining Diabetes Prevalence: a Rational Basis for the Use of Fasting Plasma Glucose Concentrations?Diabetic Medicine, 1990